All payments made in the preview are in test mode. Read more

Controlled and state law

If a compound is not on the controlled substances list but is chemically similar to one, is it automatically legal?

Plain English first, then the primary source. Education, not legal advice.

Interpretation

In short: controlled-substance analysis is chemical and fact-specific, and most peptides sit outside it. Assume nothing without checking.

Plain English

The Controlled Substance Analogue Act, 21 U.S.C. 813, provides that a controlled substance analogue is treated, for federal law purposes, as a Schedule I controlled substance if it is intended for human consumption. An analogue is generally a substance with a chemical structure substantially similar to a Schedule I or II substance, and either a similar or claimed similar pharmacological effect.

This means structural novelty alone does not guarantee legality. Whether a substance qualifies as an analogue, and whether it was 'intended for human consumption', are questions that have been litigated and are decided case by case, often turning heavily on marketing, packaging, and surrounding evidence of intent.

This general rule of federal law exists alongside separate state controlled substance schedules and analogue statutes, which can be broader or differently structured than the federal version.

Why it matters

  • This is directly relevant to novel research chemicals that are structurally related to controlled substances but not explicitly scheduled.

Where the answer becomes fact-specific

The Foundation does not manufacture legal conclusions. These points change the analysis and may require qualified regulatory counsel.

  • The outcome depends on structural comparison, pharmacological evidence, and proof of intent for human consumption, all of which are evaluated on the specific facts of a case.
  • State-level controlled substance and analogue laws vary and must be checked separately from federal law.

View the source

Covered in

Back to the Regulatory Library